Medicare Part D coverage · mebendazole · RxCUI 1737789
mebendazole 100 MG Chewable Tablet [Emverm]
Per the CMS 2026 Part D formulary file, mebendazole 100 MG Chewable Tablet [Emverm] is covered by 2,046 Medicare Part D plans (40.5% of enrollable products), averaging Tier 4.3, with prior authorization required on 1% of covering formularies.
- 40.5%
- Plan coverage
- 2,046
- Plans covering
- T4.3
- Avg tier
- 1%
- Prior auth required
What the CMS Formulary Data Shows for mebendazole 100 MG Chewable Tablet [Emverm]
Per the CMS 2026 Part D formulary file, mebendazole 100 MG Chewable Tablet [Emverm] (RxNorm concept RXCUI 1737789, generic name mebendazole) appears on 104 distinct formulary files spanning 2,046 Medicare Part D plan offerings - 40.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.3.
Real-world access to mebendazole 100 MG Chewable Tablet [Emverm] depends on utilization management as much as tier placement: 1% of covering formularies require prior authorization. 0% require step therapy. 54.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,226 Part D beneficiaries filled mebendazole 100 MG Chewable Tablet [Emverm] in 2023, with total plan-and-beneficiary spending of $5,029,155 and an average per-beneficiary annual cost of $4,102.08. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry mebendazole 100 MG Chewable Tablet [Emverm] today.
Coverage Details
- Formularies covering
- 104
- Plans covering
- 2,046
- Coverage rate
- 40.5%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 54.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,226
- Total spending
- $5,029,155
- Avg per beneficiary
- $4,102.08
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering mebendazole 100 MG Chewable Tablet [Emverm]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
Show the next 30 plans
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | No | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | No | $4.80 | FL |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | No | $4.80 | FL |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | No | $15.20 | IL |
| WellSense Added Value (HMO) | Boston Medical Center Health Plan, Inc. | T1 | No | $21.70 | NH |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | No | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | No | $27.70 | AL |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Colorado, Inc. | T1 | No | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF North Carolina, Inc. | T1 | No | $36.20 | NC |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $40.00 | NJ |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | Elderplan, Inc. | T1 | No | $44.80 | NY |
| ElderServe Star (HMO I-SNP) | Elderserve Health, Inc. | T1 | No | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF NEW York, Inc. | T1 | No | $58.80 | NY |
| MetroPlus Platinum Plan (HMO) | Metroplus Health Plan, Inc. | T1 | No | $58.80 | NY |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T4 | No | $0 | FL |
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
| Optimum Emerald Full (HMO D-SNP) | Optimum Healthcare, Inc. | T4 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is mebendazole 100 MG Chewable Tablet [Emverm] covered by Medicare Part D?
Yes, mebendazole 100 MG Chewable Tablet [Emverm] is covered by 2,046 Medicare Part D plans (40.5% of all Part D formularies).
What tier is mebendazole 100 MG Chewable Tablet [Emverm] on Medicare Part D plans?
mebendazole 100 MG Chewable Tablet [Emverm] averages Tier 4.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does mebendazole 100 MG Chewable Tablet [Emverm] require prior authorization?
1% of Part D formularies require prior authorization for mebendazole 100 MG Chewable Tablet [Emverm]. Step therapy: 0%. Quantity limits: 54.8%.
How much does Medicare spend on mebendazole 100 MG Chewable Tablet [Emverm]?
In 2023, total Medicare Part D spending on mebendazole 100 MG Chewable Tablet [Emverm] was $5,029,155, covering 1,226 beneficiaries. The average spend per beneficiary was $4,102.08.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- sapropterin dihydrochloride 100 MG Powder for Oral Solution T4.3
- C1 esterase inhibitor (human) 2000 UNT Injection [Haegarda] T4.3
- tolvaptan 15 MG Oral Tablet T4.3
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] T4.3
- pirfenidone 534 MG Oral Tablet T4.3
- 0.5 ML ustekinumab 90 MG/ML Prefilled Syringe [Stelara] T4.3
Similar prior-authorization rate
- acetaminophen 325 MG / tramadol hydrochloride 37.5 MG Oral Tablet 1% PA
- morphine sulfate 2 MG/ML Oral Solution 1% PA
- 500 ML sodium chloride 30 MG/ML Injection 1% PA
- 500 ML sodium chloride 50 MG/ML Injection 1% PA
- dextroamphetamine sulfate 10 MG Oral Tablet 1% PA
- dronedarone 400 MG Oral Tablet [Multaq] 1% PA